Inmune Bio Files 8-K for Corporate Amendments
Ticker: INMB · Form: 8-K · Filed: May 23, 2024 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | May 23, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-amendment, financial-filing
Related Tickers: INMB
TL;DR
INMB filed an 8-K for corporate updates and financials.
AI Summary
On May 22, 2024, Inmune Bio, Inc. filed an 8-K report detailing amendments to its Articles of Incorporation and the filing of financial statements and exhibits. The company, incorporated in Nevada with its principal executive offices in Boca Raton, Florida, operates in the biological products sector.
Why It Matters
This filing indicates corporate housekeeping and the submission of required financial documents, which are standard procedures for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine filing for corporate amendments and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- May 22, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Boca Raton, FL (location) — Address of Principal Executive Offices
FAQ
What specific amendments were made to the Articles of Incorporation?
The filing indicates amendments to the Articles of Incorporation but does not specify the exact nature of these amendments in the provided text.
What financial statements and exhibits were filed?
The filing states that Financial Statements and Exhibits were filed, but the specific details of these documents are not included in the provided excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated May 22, 2024.
What is Inmune Bio, Inc.'s state of incorporation?
Inmune Bio, Inc. is incorporated in Nevada.
Where are Inmune Bio, Inc.'s principal executive offices located?
The principal executive offices of Inmune Bio, Inc. are located at 225 NE Mizner Boulevard, Suite 640, Boca Raton, FL 33432.
Filing Stats: 493 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-05-23 16:00:10
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per shares INMB The NASDAQ Stock Ma
Filing Documents
- ea0206791-8k_inmune.htm (8-K) — 34KB
- ea020679101ex3-1_inmune.htm (EX-3.1) — 4KB
- 0001213900-24-046252.txt ( ) — 213KB
- inmb-20240522.xsd (EX-101.SCH) — 3KB
- inmb-20240522_lab.xml (EX-101.LAB) — 33KB
- inmb-20240522_pre.xml (EX-101.PRE) — 22KB
- ea0206791-8k_inmune_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INMUNE BIO INC. Date: May 23, 2024 By: /s/ David Moss David Moss Chief Financial Officer 2